Literature DB >> 2583041

Enterohepatic circulation of triiodothyronine (T3) in rats: importance of the microflora for the liberation and reabsorption of T3 from biliary T3 conjugates.

M Rutgers1, F A Heusdens, F Bonthuis, W W de Herder, M P Hazenberg, T J Visser.   

Abstract

In normal rats, T3 glucuronide (T3G) is the major biliary T3 metabolite, but excretion of T3 sulfate (T3S) is greatly increased after inhibition of type I deiodinase, e.g. with 6-propyl-2-thiouracil (PTU). In this study, the fate of the T3 conjugates excreted with bile was studied to assess the significance of a putative enterohepatic circulation of T3 in rats. Conventional (CV) or intestine-decontaminated (ID) rats received iv [125I]T3G or [125I]T3S, the latter usually after pretreatment with PTU (1 mg/100 g BW). Radioactivity in plasma and bile or feces was analyzed by Sephadex LH-20 chromatography and HPLC. Within 1 h, 88% of injected T3G was excreted in bile of CV or ID rats, independent of PTU. About 75% of the injected T3S was excreted within 4 h in PTU-treated rats, in contrast to only 20% in controls. Up to 13 h after iv administration of T3G or T3S (+PTU) to intact ID and CV rats, fecal radioactivity consisted of more than 90% T3 in all CV rats, 95% of T3S in T3S-injected ID rats, and 30% T3 and 67% T3G in T3G-injected ID rats. In overnight-fasted CV rats injected with T3G, total plasma radioactivity rapidly declined until a nadir of 0.10% dose/ml at about 2.5 h, but radioactivity reappeared with a broad maximum of 0.12% dose/ml between 5.5-10 h. In the latter phase, plasma radioactivity consisted of predominantly I- and T3 in a ratio of 2:1. Reabsorption was diminished in fed CV rats and prevented in ID rats. Plasma T3 4-10 h after iv T3G injection to overnight-fasted CV rats was 12, 2, and 3 times higher than that in bile-diverted rats, fed CV rats, and ID rats, respectively, and similar to that 4 h after the injection of T3 itself. Total plasma radioactivity as well as plasma T3 6-13 h after iv administration T3S in PTU-treated rats were significantly increased in CV vs. ID rats, e.g. T3 0.016% vs. 0.005% dose/ml. These results demonstrate a significant enterohepatic circulation of T3 in rats in which bacterial hydrolysis of T3 conjugates excreted with bile plays an important role.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583041     DOI: 10.1210/endo-125-6-2822

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Effects of thyroid status and thyrostatic drugs on hepatic glucuronidation of lodothyronines and other substrates in rats : Induction of phenol UDP-glucuronyltransferase by methimazole.

Authors:  T J Visser; E Kaptein; A Gijzel; W W de Herder; M L Cannon; F Bonthuis; W J de Greef
Journal:  Endocrine       Date:  1996-02       Impact factor: 3.633

2.  Ester-to-amide rearrangement of ethanolamine-derived prodrugs of sobetirome with increased blood-brain barrier penetration.

Authors:  Skylar J Ferrara; J Matthew Meinig; Andrew T Placzek; Tapasree Banerji; Peter McTigue; Meredith D Hartley; Hannah S Sanford-Crane; Tania Banerji; Dennis Bourdette; Thomas S Scanlan
Journal:  Bioorg Med Chem       Date:  2017-03-23       Impact factor: 3.641

3.  Circulating Thyroid Hormone Profile in Response to a Triiodothyronine Challenge in Familial Longevity.

Authors:  Ana Zutinic; Gerard J Blauw; Hanno Pijl; Bart E Ballieux; Rudi G J Westendorp; Ferdinand Roelfsema; Diana van Heemst
Journal:  J Endocr Soc       Date:  2020-08-20

4.  Comparison of 3,5,3'-triiodo-L-thyronine and L-thyroxine absorption from the intestinal lumen of the fasted rainbow trout, Oncorhynchus mykiss.

Authors:  A Whitaker; J G Eales
Journal:  Fish Physiol Biochem       Date:  1993-03       Impact factor: 2.794

Review 5.  Enteric Microbiota⁻Gut⁻Brain Axis from the Perspective of Nuclear Receptors.

Authors:  Kalina Duszka; Walter Wahli
Journal:  Int J Mol Sci       Date:  2018-07-28       Impact factor: 5.923

6.  Treatment of Hypothyroid Patients With L-Thyroxine (L-T4) Plus Triiodothyronine Sulfate (T3S). A Phase II, Open-Label, Single Center, Parallel Groups Study on Therapeutic Efficacy and Tolerability.

Authors:  Ferruccio Santini; Giovanni Ceccarini; Caterina Pelosini; Monica Giannetti; Ilaria Ricco; Giorgia Querci; Enzo Grossi; Giorgio Saponati; Paolo Vitti
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-29       Impact factor: 5.555

7.  Non-Invasive Measurement of Thyroid Hormones in Domestic Rabbits.

Authors:  Maria Chmurska-Gąsowska; Natalia Sowińska; Sylwia Pałka; Michał Kmiecik; Joanna Lenarczyk-Knapik; Łukasz Migdał
Journal:  Animals (Basel)       Date:  2021-04-21       Impact factor: 2.752

Review 8.  The relationships between the gut microbiota and its metabolites with thyroid diseases.

Authors:  Wen Jiang; Ganghua Lu; Dingwei Gao; Zhongwei Lv; Dan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-18       Impact factor: 6.055

Review 9.  Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis.

Authors:  G C Hard
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.